SEC-sourced researchBeta

SGMOQ

SANGAMO THERAPEUTICS, INC

US markets

Data passport

CIK: 0001001233
Exchange: OTC
Business activity: — · SIC 2836
Financial inputs: 6/6
Filing date: Oct 7, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

SGMOQ · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2024	57,800,000.0000	Mar 30, 2026
December 2025	39,552,000.0000	Mar 30, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	39,552,000.0000	-122,932,000.0000	-97,208,000.0000	59,745,000.0000	74,013,000.0000	Mar 30, 2026
December 2024	57,800,000.0000	-97,941,000.0000	-67,139,000.0000	101,635,000.0000	78,865,000.0000	Mar 30, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$39.55M	December 2025	Mar 30, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$57.8M	December 2024	Mar 30, 2026	10-K
Net incomeNetIncomeLoss	-$122.93M	December 2025	Mar 30, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$97.21M	December 2025	Mar 30, 2026	10-K
Total assetsAssets	$59.75M	December 2025	Mar 30, 2026	10-K
Total liabilitiesLiabilities	$74.01M	December 2025	Mar 30, 2026	10-K

New filings

Explore methodology ↗